The stock price of Astrazeneca on September 22, 2023, at 08:43 am in London, was determined to be 10,886 GBP. The stock belongs to the “Pharmaceuticals” segment.
The current assessment of Astrazeneca is derived from a multi-step analysis. Eight categories have been selected, each leading to a “Buy”, “Hold”, or “Sell” recommendation. These results are then consolidated for an overall assessment.
1. Technical Analysis: Astrazeneca’s stock price of 10,886 GBP is currently +1.02% away from the 50-day moving average (GD50), indicating a “Hold” recommendation for the short term. However, based on the past 200 days, the stock is -2.79% below the GD200, resulting in a “Hold” recommendation for the long term. Overall, the stock is assessed as “Hold” from a technical analysis perspective for both time periods.
2. Sentiment and Buzz: The analysis of communication on the internet is also considered in the assessment of a stock. Over the past months, Astrazeneca has shown increased online activity, indicating a higher level of discussion. Hence, the stock receives a “Buy” recommendation for this factor. However, the rate of change in sentiment has been negative, leading to a “Sell” recommendation. Overall, Astrazeneca is considered a “Sell” stock.
3. Industry Comparison: Astrazeneca achieved a return of 2.86% in the past year, outperforming other stocks in the “Healthcare” sector by 15.83% (compared to an average return of -12.98%). The average annual return for stocks in the “Pharmaceuticals” sector is -10.68%, and Astrazeneca currently surpasses it by 13.54%. Due to this overperformance, the stock is given a “Buy” rating at this level.
In conclusion, the analysis suggests that investors should consider buying or holding Astrazeneca’s stock. The analysis provides insights into the future development of the stock and why action should be taken.